Evogene (EVGN) Receivables - Other (2012 - 2025)

Evogene has disclosed Receivables - Other across 14 years of filings, most recently posting $706000.0 for Q4 2025.

• In Q4 2025, Receivables - Other rose 1207.41% year-over-year to $706000.0; the TTM figure through Dec 2025 stood at $706000.0 (up 1207.41% YoY), while the FY2025 annual figure was $706000.0, up 1207.41% from the prior year.
• Receivables - Other came in at $706000.0 for Q4 2025 at Evogene, up from $451000.0 in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $1.0 million in Q2 2021 to a low of $8000.0 in Q4 2021.
• Average Receivables - Other over 5 years is $296750.0, with a median of $132500.0 recorded in 2023.
• Year-over-year, Receivables - Other tumbled 88.73% in 2021 and surged 1207.41% in 2025.
• Over 5 years, Receivables - Other stood at $8000.0 in 2021, then surged by 1175.0% to $102000.0 in 2022, then soared by 30.39% to $133000.0 in 2023, then plunged by 59.4% to $54000.0 in 2024, then surged by 1207.41% to $706000.0 in 2025.
• Per Business Quant data, the three most recent Receivables - Other figures were $706000.0 in Q4 2025, $451000.0 in Q3 2025, and $132000.0 in Q2 2025.